search
Back to results

Comparison Between Oral and Enema of Chloral Hydrate

Primary Purpose

Congenital Cataract

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
oral chloral hydrate
enema chloral hydrate
Sponsored by
Sun Yat-sen University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Congenital Cataract focused on measuring pediatric ophthalmic examination, chloral hydrate, Effects Comparison

Eligibility Criteria

3 Months - 36 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • diagnosed with congenital cataract aged from 3 to 36 months weight from 5 to 15 kg with American Society of Anesthesiologists (ASA) physical status 1-2

Exclusion Criteria:

  • with gastro-esophageal reflux, nausea and vomiting, apnea in the past 3 months recent pneumonia exacerbation of asthma, bronchitis and upper respiratory tract infection bradycardia, and facial abnormalities, allergy to chloral hydrate, weight <2 or >20 kg .

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Experimental

    Arm Label

    oral group

    enema group

    Arm Description

    Outcomes

    Primary Outcome Measures

    Demography (age, sex, weight, laterality and medical history)
    The demography of cataract and healthy children were recorded by using a semi-structured questionnaire

    Secondary Outcome Measures

    Side effect
    record the following symptom: Vomit after administration、Cough、SpO2 < 95%、SpO2 < 90%、New vomiting、Resume normal activity over 8 hour、Poor appetite、Altered bowel habit
    the time of Sleepiness:Onset time (min)
    the time of Sleepiness:Duration of examination (min)
    the time of Sleepiness:Recovery time (min)

    Full Information

    First Posted
    July 30, 2017
    Last Updated
    August 3, 2017
    Sponsor
    Sun Yat-sen University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03242629
    Brief Title
    Comparison Between Oral and Enema of Chloral Hydrate
    Official Title
    Effects Comparison Between Oral and Enema of Chloral Hydrate in Pediatric Ophthalmic Examination
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2017
    Overall Recruitment Status
    Completed
    Study Start Date
    January 2017 (Actual)
    Primary Completion Date
    July 2017 (Actual)
    Study Completion Date
    July 2017 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Sun Yat-sen University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    To compare the clinical sedative effect and safety using 10% chloral hydrate during ophthalmic examinations for oral vs enema group.The patients were randomly divided into two groups (oral group and enema group) using a computer random number generator with a 1:1 allocation (simple randomization, odd number for oral group and even number for enema group).
    Detailed Description
    To compare the clinical sedative effect and safety using 10% chloral hydrate during ophthalmic examinations for oral vs enema group.The patients were randomly divided into two groups (oral group and enema group) using a computer random number generator with a 1:1 allocation (simple randomization, odd number for oral group and even number for enema group).One hundred and twenty children aged from 3 to 36 months (5-15 kg) scheduled to ophthalmic examinations were randomly sedated by oral chloral hydrate(80 mg×kg-1, n = 60) or enema chloral hydrate(80 mg×kg-1, n = 60). The primary endpoint was successful sedation to complete the examinations including slit-lamp photography, tonometry, anterior segment analysis, and refractive error inspection. The secondary endpoints included onset time, duration of examination, recovery time, discharge time, any side effects during examination, and within 48 h after discharge.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Congenital Cataract
    Keywords
    pediatric ophthalmic examination, chloral hydrate, Effects Comparison

    7. Study Design

    Primary Purpose
    Other
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    120 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    oral group
    Arm Type
    Active Comparator
    Arm Title
    enema group
    Arm Type
    Experimental
    Intervention Type
    Drug
    Intervention Name(s)
    oral chloral hydrate
    Intervention Description
    Chloral hydrate syrup was available in a concentration of 100 mg×ml-1.The children assigned to receive 0.8 ml×kg-1 of chloral hydrate (80 mg×kg-1) by oral.
    Intervention Type
    Drug
    Intervention Name(s)
    enema chloral hydrate
    Intervention Description
    Chloral hydrate syrup was available in a concentration of 100 mg×ml-1 at our hospital.The children assigned to receive 0.8 ml×kg-1 of chloral hydrate (80 mg×kg-1) by enema.
    Primary Outcome Measure Information:
    Title
    Demography (age, sex, weight, laterality and medical history)
    Description
    The demography of cataract and healthy children were recorded by using a semi-structured questionnaire
    Time Frame
    baseline
    Secondary Outcome Measure Information:
    Title
    Side effect
    Description
    record the following symptom: Vomit after administration、Cough、SpO2 < 95%、SpO2 < 90%、New vomiting、Resume normal activity over 8 hour、Poor appetite、Altered bowel habit
    Time Frame
    the following 48 hour after using the drug
    Title
    the time of Sleepiness:Onset time (min)
    Time Frame
    baseline
    Title
    the time of Sleepiness:Duration of examination (min)
    Time Frame
    baseline
    Title
    the time of Sleepiness:Recovery time (min)
    Time Frame
    baseline

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    3 Months
    Maximum Age & Unit of Time
    36 Months
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: diagnosed with congenital cataract aged from 3 to 36 months weight from 5 to 15 kg with American Society of Anesthesiologists (ASA) physical status 1-2 Exclusion Criteria: with gastro-esophageal reflux, nausea and vomiting, apnea in the past 3 months recent pneumonia exacerbation of asthma, bronchitis and upper respiratory tract infection bradycardia, and facial abnormalities, allergy to chloral hydrate, weight <2 or >20 kg .
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Haotian Lin, M.D,Ph.D
    Organizational Affiliation
    Zhongshan Ophthalmic Center, Sun Yat-sen University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Comparison Between Oral and Enema of Chloral Hydrate

    We'll reach out to this number within 24 hrs